NCT06529211

Brief Summary

This study aims to determine the differences between the effect of ultrasound cavitation and whole-body vibration on abdominal fat in obese adolescent females

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 22, 2024

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

July 26, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 31, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2024

Completed
Last Updated

July 31, 2024

Status Verified

July 1, 2024

Enrollment Period

3 months

First QC Date

July 26, 2024

Last Update Submit

July 26, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Weight

    Within 6 weeks

  • BMI

    Weight/ height scale will be used to measure the weight and height of all females in all groups to calculate their BMI before and after treatment according to the following equation BMI = weight/ height² (kg/m²)

    Within 6 weeks

  • Waist circumference

    It is a measurement taken around the waist at the level of the narrowest part of the torso, typically located between the bottom of the rib cage and the top of the hip bones (iliac crest). It is used as an indicator of central obesity. However, as a general guideline, a waist circumference of over 35 inches (88 cm) in women is often considered high and indicative of an increased health risk .

    Within 6 weeks

  • Waist to hip ratio (WHR)

    Waist-to-hip ratio (WHR) is a measurement that compares the circumference of the waist to that of the hips. The waist circumference is measured at the narrowest point of the torso, usually just above the belly button (umbilicus), and the hip circumference is measured at the widest part, 9 around the buttocks at level of greater trochanters; then dividing the waist circumference by the hip circumference. The formula is as follows: WHR = Waist Circumference / Hip Circumference. For women, a WHR above 0.85 is often considered high and indicative of an increased health risk.

    Within 6 weeks

  • Abdominal skinfold thickness

    Abdominal skinfold thickness is a specific measurement used to estimate the amount of subcutaneous fat in that area. It provides insights into the distribution of fat in the abdominal region. The measurement is typically taken at a site approximately 2 cm to the right side of the belly button, and the skinfold is pinched with calipers to measure the thickness. The measurement process involves firmly grasping the skin and underlying fat tissue with the calipers, ensuring that only the skin and fat are included in the measurement and not muscle or other tissues. The measurement is recorded in millimeters (mm)

    Within 6 weeks

  • Bioelectrical impedance analysis (BIA)

    In BIA, a small, safe electrical current is passed through the body using electrodes typically placed on the hands and feet. The electrical current encounters resistance from tissues with lower water content, such as fat and bone, while it easily passes through tissues with higher water content, such as muscle. By measuring the impedance (resistance and reactance) of the electrical current, BIA devices can estimate body composition parameters such as body fat percentage, lean body mass, and hydration levels. BIA can provide a quick and non-invasive estimation of body composition. Also, it is a useful tool for tracking changes in body composition over time and monitoring progress in fitness or weight loss programs.

    Within 6 weeks

Study Arms (3)

Low caloric diet group

ACTIVE COMPARATOR

low-caloric diet of 1500 kcal/day.

Dietary Supplement: Low caloric diet

ultrasound cavitation group

EXPERIMENTAL

The participants will be treated by ultrasound cavitation, in addition to the low-caloric diet of 1500 kcal/day.

Dietary Supplement: Low caloric dietDevice: Ultrasound cavitation

whole-body vibration group

EXPERIMENTAL

The participants will be treated by whole body vibration, in addition to the low-caloric diet of 1500 kcal/day.

Dietary Supplement: Low caloric dietDevice: Whole body vibration

Interventions

Low caloric dietDIETARY_SUPPLEMENT

Low caloric diet: the participants will receive low caloric diet program (1500 Kcal/ day) for 6 weeks as follows: 45% carbohydrate, 20% fat and 35% proteins of total calorie intake.

Low caloric diet groupultrasound cavitation groupwhole-body vibration group

Ultrasound cavitation + Low caloric diet Low caloric diet program (1500 Kcal/ day): for 6 weeks. Ultrasound cavitation: It will be on abdomen for 30 minutes/session, 2 sessions/week for 6 weeks as follows: * The participants will be in supine lying position and the abdomen is divided into two sides right and left from the midline. * The Ultrasound pulsed waves will be set with power input (AC100/ 240V), frequency (40 KHz), and Power output (45W). This will be for 15 minutes on each abdominal side.

ultrasound cavitation group

Whole body vibration + Low caloric diet Low caloric diet program (1500 Kcal/ day) for 6 weeks. Whole body vibration: for 30 minutes/session, 2 sessions/week for 6 weeks as follows: * The participants will begin with a brief warm-up for 5 minutes by doing deep breathing exercises. * Then they will stand with feet shoulder-width apart on the platform while holding handrails to maintain balance and stability. They will be instructed to relax and allow the vibrations to pass through her body. This will be applied for 20 minutes per session. * The vibration will be started with lower settings and gradually will be increased till the desired frequency and amplitude (45 HZ) will be reached. * After the session will be completed, the participant will be instructed to cool down gradually by doing deep breathing for 5 minutes to help their body to return to a resting state. They will be advised to drink plenty of water to be hydrated and recovered after the WBV session.

whole-body vibration group

Eligibility Criteria

Age17 Years - 25 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAdolescent females
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescent females suffer from abdominal obesity.
  • Their ages will be ranged from 17 to 25 years old.
  • Their body mass index (BMI) will be ranged from 30 to 35 kg/m2.
  • Their waist circumference will be \> 88 cm.
  • Their WHR will be more than 0.88.

You may not qualify if:

  • Females will be excluded from the study if they have:
  • Thyroid, hepatic and kidney disorders.
  • Diabetes mellitus, coronary artery diseases, hypertension and congestive heart failure.
  • Recent abdominal surgical scar or umbilical hernia.
  • History of orthopedic implants insertion or cardiac pacemaker implantation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Obesity, Abdominal

Interventions

Caloric Restriction

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Azza Kassab

    Cairo University

    STUDY CHAIR
  • Manal El-Shafei

    Cairo University

    STUDY DIRECTOR
  • Mohamed AboEleinen

    Cairo University

    STUDY DIRECTOR

Central Study Contacts

Christina yassa, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

July 26, 2024

First Posted

July 31, 2024

Study Start

July 22, 2024

Primary Completion

November 1, 2024

Study Completion

December 10, 2024

Last Updated

July 31, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL